YOLFTbeta
00

Yungjin Pharm Co Ltd

003520 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

795.00KRW+21.00 (+2.71%)

Price History

Full chart

Market Stats

Previous Close774.00
Open783.00
Day Range772.00 – 828.00
52-Week Range998.00 – 2,320.00
Volume669.68K
Market Cap191.31B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.71
50-Day Avg1,137.48
200-Day Avg1,540.04

About

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Kisoo Lee
  • Employees574
  • HeadquartersJamsil Company Building, Seoul, South Korea, 05510, Korea
  • Websitehttps://www.yungjin.co.kr

Leadership

  • Mr. Kisoo LeeChairman of the Board of Directors, President & CEO · b. 1966
  • Mr. ByeongHo ParkCFO & MD · b. 1967
  • Mr. UngYeol YangMD & GM of Sales HQ · b. 1977
  • Mr. Joongyoun ChoMD & Global Headquarters GM · b. 1979
  • Mr. HongJun ParkManaging Director · b. 1974
  • Mr. UngGyu LeeVice President · b. 1972

Financials

Income Statement

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue156.62B167.57B170.20B193.13B195.01B186.41B220.52B208.46B196.07B218.38B234.90B252.04B254.26B
Growth (%)-+6.99%+1.57%+13.47%+0.97%-4.41%+18.30%-5.47%-5.95%+11.38%+7.57%+7.30%+0.88%
Cost of Revenue99.72B106.48B105.52B121.89B126.17B124.97B140.74B135.00B138.13B153.65B162.78B171.69B177.10B
Gross Profit56.90B61.09B64.69B71.25B68.84B61.44B79.77B73.46B57.94B64.73B72.12B80.35B77.16B
Gross Margin36.33%36.46%38.01%36.89%35.30%32.96%36.18%35.24%29.55%29.64%30.70%31.88%30.35%
Operating Expense49.98B54.11B59.64B65.79B65.81B63.63B69.79B73.08B71.81B72.10B69.00B71.63B72.33B
Operating Income6.92B6.98B5.05B5.45B3.03B-2.19B9.98B381.45M-13.88B-7.36B3.12B8.72B4.82B
Operating Margin4.42%4.16%2.97%2.82%1.55%-1.17%4.53%0.18%-7.08%-3.37%1.33%3.46%1.90%
EBITDA----9.85B263.21M17.63B8.27B-6.56B-14.30B7.65B16.87B12.76B
EBITDA Margin----5.05%0.14%7.99%3.97%-3.34%-6.55%3.26%6.69%5.02%
Net Income11.74B909.09M3.39B4.20B1.87B-6.10B5.03B-133.12M-11.58B-21.96B-3.88B1.23B-227.66M
Net Income Margin7.50%0.54%1.99%2.18%0.96%-3.27%2.28%-0.06%-5.91%-10.06%-1.65%0.49%-0.09%
R&D8.58B9.31B11.79B12.66B13.93B11.99B13.51B15.07B13.26B14.36B11.91B11.60B10.30B
R&D as % of Total Revenue5.48%5.55%6.93%6.56%7.14%6.43%6.13%7.23%6.76%6.58%5.07%4.60%4.05%
Interest Expense00000272.63M0253.25M208.97M736.57M2.88B5.27B4.18B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.15%0.00%0.12%0.11%0.34%1.22%2.09%1.65%

Balance Sheet

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets169.33B178.97B193.70B199.35B203.85B196.11B200.45B188.10B194.10B203.08B226.60B234.26B262.38B
Total Liabilities66.89B78.18B93.27B93.19B84.20B84.51B84.69B73.67B89.21B113.21B136.97B144.45B170.93B
Total Equity102.45B100.79B100.42B106.17B119.65B111.61B115.75B114.43B104.89B89.87B89.63B89.80B91.46B
Cash8.45B1.14B4.52B1.67B4.19B1.83B651.87M427.69M464.57M682.25M7.21B3.44B28.43B
Net Debt----13.97B10.46B13.17B6.03B10.83B37.94B58.17B60.95B64.02B

Cash Flow

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.95B6.22B8.80B3.11B3.15B1.27B9.28B14.50B8.37B-11.61B-10.22B21.74B11.73B
Investing Cash Flow5.64B-11.40B-12.52B-821.01M4.34B--------
Financing Cash Flow-5.82B-2.13B7.10B-5.15B-4.97B--------
Capital Expenditure6.63B11.30B13.75B4.69B10.59B4.71B10.36B6.30B11.32B13.20B10.24B21.61B11.96B
Free Cash Flow-----7.84B-3.43B-1.08B8.19B-2.95B-24.81B-20.46B133.66M-233.53M
FCF to OCF-----248.66%-269.47%-11.58%56.51%-35.28%213.70%200.13%0.61%-1.99%

Earnings

Report DateMar 31, 2003Feb 28, 2007May 14, 2007Feb 27, 2008Feb 25, 2009Jun 3, 2009Sep 2, 2009Dec 2, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 30, 2016Jan 18, 2017Apr 26, 2017Jul 26, 2017Oct 25, 2017Jan 19, 2018May 9, 2018Jul 31, 2018Oct 29, 2018Feb 14, 2019May 8, 2019Aug 6, 2019Nov 5, 2019Feb 6, 2020May 12, 2020Aug 5, 2020Nov 3, 2020Feb 3, 2021May 16, 2021Jul 30, 2021Nov 3, 2021Feb 9, 2022May 9, 2022Jul 29, 2022Nov 2, 2022Feb 8, 2023May 15, 2023Jul 28, 2023Nov 7, 2023Mar 4, 2024May 7, 2024Aug 14, 2024Nov 14, 2024May 15, 2025Jul 30, 2025Oct 29, 2025Dec 31, 2025May 5, 2026Jun 30, 2026
EPS Estimate---1.45-----------------------------------------------------------------------
EPS Actual-17.16-32.16-19.54-28.02-47.11-6.95-16.22-6.90-2.56-31.1118.045.61-8.368.572.911.022.03-17.886.1514.047.7910.4120.789.0325.88-8.181.193.958.157.140.933.377.625.4610.509.47-1.778.685.113.66-7.171.88-11.77-14.89-8.589.5418.8715.62-16.5310.004.00-2.00-13.35-10.00-23.00-21.00-9.34-9.34-7.74-11.47-92.92-0.84-9.19-4.79-6.3722.38-7.96-2.39-5.291.85-6.38-2.05-12.48-13.29
Surprise---1247.59%-----------------------------------------------------------------------
Timing--After-hours---------------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap191.31B
Enterprise Value260.57B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.07
Price / Book2.17
Revenue (TTM)179.50B
Gross Profit (TTM)57.75B
EBITDA788.96M
Profit Margin-3.26%
Operating Margin-6.66%
Return on Equity-4.98%
Return on Assets-1.83%
Shares Outstanding182.89M
Shares Float86.92M
Beta0.71
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

19971×
400.54Jan 3, 1997
19961×
200.27Jan 3, 1996

Stock Splits

  • Mar 5, 200410:5